GlassScriptPhysician profile
Angela Rumore
$2,198.50
in general payments reported to CMS, 2019-2025
15 companies · $425 in 2025
The $425 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $266 · 2023: $627 · 2024: $881 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $321.97 | 2023-2024 | Livtencity |
| Becton, Dickinson and Company | $308.78 | 2024 | Powerglide, Provena Midline |
| Abiomed | $192.54 | 2025 | |
| Astellas Pharma Global Development | $164.50 | 2024 | Padcev |
| Bard Access Systems, INC. | $140.86 | 2022 | |
| Amgen INC. | $129.38 | 2024 | Tavneos |
| Astrazeneca Pharmaceuticals LP | $124.95 | 2024 | Andexxa |
| Janssen Biotech, INC. | $124.95 | 2022 | |
| Pharmacosmos Therapeutics INC. | $119.52 | 2023 | Monoferric |
| Argenx US, INC. | $117.44 | 2025 | |
| La Jolla Pharmaceutical Company | $114.74 | 2025 | Giapreza |
| Edwards Lifesciences Corporation | $103.60 | 2023 | Hemosphere |
| Jazz Pharmaceuticals INC. | $95.63 | 2023 | Zepzelca |
| Csl Behring | $73.99 | 2024 | Hizentra |
| Stryker Corporation | $65.65 | 2023 | Prevalon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Rumore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.